Cargando…

Thrombosis Associated With Cytomegalovirus (CMV) in a Kidney Transplant Recipient

Cytomegalovirus (CMV) infection is a common infectious complication after kidney transplantation. Indirect effects of CMV infection include an increased risk of secondary infections, increased risk of acute rejection, and chronic allograft dysfunction. However, it is not well known that CMV may also...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Lin, Hsu, Young, Sharma, Neeraj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2021
Materias:	Nephrology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492551/ https://www.ncbi.nlm.nih.gov/pubmed/34659958 http://dx.doi.org/10.7759/cureus.17745

Ejemplares similares

Kidney Transplant Outcomes in Recipients Over the Age of 70
por: Mehta, Jaya, et al.
Publicado: (2023)

Immune monitoring of allograft status in kidney transplant recipients
por: Han, Hwarang S., et al.
Publicado: (2023)

Screening of cognitive performance in kidney transplant recipients: a mini review
por: Schietzel, Simeon, et al.
Publicado: (2023)

Cemiplimab for advanced cutaneous squamous cell carcinoma in kidney transplant recipients
por: Van Meerhaeghe, T., et al.
Publicado: (2022)

Optimal use of SGLT2 inhibitors in diabetic kidney transplant recipients
por: Pham, Phuong-Thu T., et al.
Publicado: (2022)

Graft and Patient Survival in Kidney Transplant Recipients Over the Age of Sıxty-Five
por: Yilmaz, Gulay, et al.
Publicado: (2022)

Value and limitations of sonography in kidney transplant recipients with special attention to the resistive index – An update
por: Stigler, Julia, et al.
Publicado: (2022)

Complications of rabbit anti-thymocyte globulin induction immunosuppression in HIV-infected kidney transplant recipients
por: Al Jurdi, Ayman, et al.
Publicado: (2022)

Cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in seropositive kidney transplant recipients
por: Lee, Hyeyoung, et al.
Publicado: (2017)

The Burden of Gastrointestinal Complaints in Kidney Transplant Recipients Using Tacrolimus With and Without Mycophenolate Mofetil: A Randomized Controlled Study
por: Fatly, Zainab Al, et al.
Publicado: (2022)

1198. Measurement of Pre-transplant Anti-cytomegalovirus (CMV) Immunoglobulin G Titer to Predict Risk of CMV Infection in CMV-seropositive Kidney Transplant Recipients
por: Kirisri, Similan, et al.
Publicado: (2020)

Medical Challenges of a Common Variable Immunodeficiency With a TNFRSF13B Gene Mutation in a Simultaneous Kidney and Pancreas Transplant Recipient
por: Coimbra, Miguel T, et al.
Publicado: (2023)

Limitations of the Karnofsky Performance Status Scale in kidney transplant recipients
por: Daoud, Ahmed Mahmoud Osman, et al.
Publicado: (2022)

Safety and Efficacy of Vedolizumab in Kidney Transplant Recipients With Crohn’s Disease
por: Busutti, Marco, et al.
Publicado: (2023)

BK Virus Nephropathy in the Native Kidney of a Liver Transplant Recipient
por: Sekulic, Miroslav, et al.
Publicado: (2021)

COVID-19–Associated Graft Loss From Renal Infarction in a Kidney Transplant Recipient
por: Webb, Christine, et al.
Publicado: (2021)

Oral Valganciclovir as a Preemptive Treatment for Cytomegalovirus (CMV) Infection in CMV-Seropositive Liver Transplant Recipients
por: Kim, Jong Man, et al.
Publicado: (2015)

Outcomes in older kidney recipients from older donors: A propensity score analysis
por: Cuadrado-Payán, Elena, et al.
Publicado: (2022)

Pulmonary Alveolar Proteinosis and Scedosporium aurantiacum Lung Infection in a Kidney Transplant Recipient
por: Amin, Sneha, et al.
Publicado: (2021)

Correlation of Cytomegalovirus (CMV) Disease Severity and Mortality With CMV Viral Burden in CMV-Seropositive Donor and CMV-Seronegative Solid Organ Transplant Recipients
por: McBride, Jacqueline M, et al.
Publicado: (2019)

The Art and Science of Kidney Transplant Offer Evaluation
por: Reddy, Nikhil A, et al.
Publicado: (2023)

Frailty and the psychosocial components of the edmonton frail scale are most associated with patient experience in older kidney transplant candidates – a secondary analysis within the kidney transplantation in older people (KTOP) study
por: Thind, Amarpreet K., et al.
Publicado: (2023)

Modest dose anti-thymocyte globulin administered intraoperatively is safe and effective in kidney transplantations: a retrospective study
por: Liu, Hui-Ying, et al.
Publicado: (2019)

A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation
por: Ljungman, Per, et al.
Publicado: (2020)

Surgical versus interventional coronary revascularization in kidney transplant recipients: a systematic review and meta-analysis
por: El-Qushayri, Amr Ehab, et al.
Publicado: (2023)

Immunological parameters associated with the severity of COVID-19 pneumonia in kidney transplant recipients
por: Ozkok, Abdullah, et al.
Publicado: (2021)

What have we learned from a case of convalescent plasma treatment in a two-time kidney transplant recipient COVID-19 patient? A case report from the perspective of viral load evolution and immune response
por: Aldunate, Fabian, et al.
Publicado: (2023)

A Bibliometric Analysis of the Most Cited Journal Articles in Kidney Transplantation
por: Rawashdeh, Badi, et al.
Publicado: (2023)

IgA-Dominant Acute Postinfectious Glomerulonephritis Presenting as Acute Renal Failure in a Kidney Transplant Recipient
por: Anand, Manish, et al.
Publicado: (2017)

1538. High Mortality of Cytomegalovirus (CMV) Pneumonia in Hematopietic Cell Transplant Recipients
por: Batista, Marjorie, et al.
Publicado: (2018)

Elevated serum osteoprotegerin may predict peripheral arterial disease after kidney transplantation: a single-center prospective cross-sectional study in Taiwan
por: Chen, Yen-Cheng, et al.
Publicado: (2017)

Kidney Recovery From Acute Kidney Injury After Hematopoietic Stem Cell Transplant: A Systematic Review and Meta-Analysis
por: Kanduri, Swetha Rani, et al.
Publicado: (2021)

1380. Real-world Effectiveness and Complications of Valganciclovir (VGC) Prophylaxis for Kidney Transplant (KT) Recipients at High Risk for Cytomegalovirus (CMV) infection (CMV Donor (D)+/Recipient (R)-)
por: Roumpz, Caroline G, et al.
Publicado: (2021)

Blood transfusions post kidney transplantation are associated with inferior allograft and patient survival—it is time for rigorous patient blood management
por: Hassan, Sevda, et al.
Publicado: (2023)

Cytomegalovirus (CMV)-specific cytotoxic T lymphocyte therapy resolve CMV diseases and refractory CMV infections in paediatric recipients of allogeneic haematopoietic stem cell transplantation
por: Wang, Xiaodong, et al.
Publicado: (2021)

Anticoagulant-Related Nephropathy in a Renal Transplant Recipient
por: Tennekoon, Hiranya D., et al.
Publicado: (2020)

Cytomegalovirus (CMV) Disease Despite Weekly Preemptive CMV Strategy for Recipients of Solid Organ and Hematopoietic Stem Cell Transplantation
por: Lodding, I P, et al.
Publicado: (2018)

Pulmonary cytomegalovirus (CMV) DNA shedding in allogeneic hematopoietic stem cell transplant recipients: Implications for the diagnosis of CMV pneumonia
por: Piñana, José Luis, et al.
Publicado: (2019)

1747. Impact of Inappropriately Low Cytomegalovirus (CMV) Prophylaxis Dosing on CMV Outcomes Among Lung Transplant (LT) Recipients
por: Watts, Corey, et al.
Publicado: (2019)

Treatment of Cytomegalovirus Infection with Cidofovir and CMV Immune Globulin in a Lung Transplant Recipient
por: Wilkens, Heinrike, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_130ta9juc7h5l44esumcjfkqce